Position in ARGX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$5,052,599
-$147,835 QoQ
Shares Held
6,919
+11.9% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Federation des caisses Desjardins du Quebec holds $43,872,219 across 136 Biotechnology names. ARGX ranks #3 (11.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,252 | $7,148,462 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
15,955 | $7,124,544 | |
| 3 | ARGX |
Argenx SE
This page
|
6,919 | $5,052,599 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
11,731 | $3,881,433 | |
| 5 | INCY |
Incyte Corp
|
31,446 | $2,959,696 | |
| 6 | TECH |
BIO-TECHNE Corp
|
38,673 | $2,021,050 | |
| 7 | MRNA |
Moderna, Inc.
|
37,887 | $1,924,658 | |
| 8 | INSM |
INSMED Inc
|
11,517 | $1,883,258 |
All Filings in ARGX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,052,599 | 6,919 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $5,200,434 | 6,184 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $4,803,727 | 6,513 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,315,588 | 6,015 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,728,837 | 2,921 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $873,915 | 1,421 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $570,810 | 1,053 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $412,408 | 959 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||